About the Company
Recro Pharma Inc. is a contract development and manufacturing organization (CDMO) with capabilities from early feasibility to commercial manufacturing. With an expertise in solving complex manufacturing problems, Recro is a leading CDMO providing oral solid dosage form development, end-to-end regulatory support, clinical and commercial manufacturing, and packaging and logistics services to the global pharmaceutical market.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $REPH News
CoreRx strikes $130M deal to snap up struggling small-molecule specialist Societal CDMO
The company also said it expected to incur a net loss of $12.1 million to $13.6 million. Recro Pharma rebranded as Societal CDMO in early 2022, several months after snapping up San Diego-based ...
Best Companies To Short As Nasdaq And Tech Stocks Retreat
Price of Intellicheck Inc compared to its Simple Moving Average Next on the Top Short list is Recro Pharma Inc, a stock that has immense downward momentum against it currently. Factor scores of C ...
Societal CDMO Inc (SCTL)
As of late, it has definitely been a great time to be an investor Recro Pharma, Inc. (NASDAQ:REPH) . The stock has moved higher by 27.8% in the past month, while it is also above... Societal CDMO ...
Why Is Biotech/Pharma Contract Service Provider Societal CDMO Stock Trading Higher On Thursday?
Privately held CoreRx Inc. will acquire Societal CDMO Inc (NASDAQ ... SCTL shares are up 132.6% at $1.07 on the last check Thursday. Recro Pharma NewsMORE Related Stocks ...
Oncology Pharma Inc ONPH
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...
Nuvectis Pharma, Inc. (NVCT)
Overall score is calculated based on proprietary scores based on sector averages in key company indicators: fair value, dividends, innovation, hiring, and insider sentiment. Note: if you don't see ...
EFTR eFFECTOR Therapeutics, Inc.
eFFECTOR Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of selective translation regulator inhibitors for the treatment of cancer. Its lead product ...
MEI Pharma Inc MEIP
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...
Nuvectis Pharma, Inc. (NASDAQ:NVCT) insiders have significant skin in the game with 67% ownership
one can better assess the future performance of a company If you want to know who really controls Nuvectis Pharma, Inc. (NASDAQ:NVCT), then you'll have to look at the makeup of its share registry.
LUMO Lumos Pharma, Inc.
Lumos Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for rare diseases. Its primary product candidate LUM-201 is an oral ...
ESSA Pharma Inc
ESSA Pharma, Inc. is a clinical stage pharmaceutical company. It engages in the business of developing small molecule drugs for the treatment of prostate cancer. The company was founded by Marianne D.
Acasti Pharma Inc. Class A
Acasti Pharma, Inc. is a biopharmaceutical company, which engages in the development and commercialization of pharmaceutical applications of its licensed rights for cardiovascular diseases.
Loading the latest forecasts...